Fatma Yurt Lambrecht
Overview
Explore the profile of Fatma Yurt Lambrecht including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
71
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yurt Lambrecht F, Ocakoglu K, Colak S, Ersoz O, Er O
Chem Biol Drug Des
. 2017 Jan;
90(1):141-146.
PMID: 28067001
Imidazolium salts and derivatives have antitumor efficacy and toxic effects in different micro-organisms. In this study, an imidazolium bromide salt (NMI) was synthesized, and its antitumor potential was investigated by...
2.
Top M, Er O, Congur G, Erdem A, Yurt Lambrecht F
Talanta
. 2016 Sep;
160:157-163.
PMID: 27591600
Topoisomerase I inhibitor topotecan (TPT) is the only single-agent therapy certified for the remedy of repetitive small cell lung cancer (SCLC). In this study, TPT was labeled with (131)I via...
3.
Yurt Lambrecht F, Ince M, Er O, Ocakoglu K, Sari F, Kayabasi C, et al.
Curr Radiopharm
. 2016 Jul;
9(3):222-227.
PMID: 27363481
Background And Objective: Pancreatic cancer is very common and difficult to diagnose in early stage. Imaging systems for diagnosing cancer have many disadvantages. However, combining different imaging modalities offers synergistic...
4.
Avsar G, Sari F, Yuzer A, Melis Soylu H, Er O, Ince M, et al.
Int J Pharm
. 2016 Apr;
505(1-2):369-75.
PMID: 27085647
A near IR absorbing phthalocyanine bearing four binaphtyl group has been synthesized in order to investigate its cytotoxicity and intracellular uptake of sensitizer on MCF-7 (human breast cancer), MDAH (ovarian...
5.
Yurt Lambrecht F, Ocakoglu K, Er O, Ince M, Gunduz C, Kayabasi C
J Labelled Comp Radiopharm
. 2016 Apr;
59(5):221-7.
PMID: 27059543
Photodynamic therapy (PDT) is based on exposing a light-sensitive material that has been localized in target tissues with visible light. In the current study, symmetric Zn(II) octaoctadodecylphthalocyanine (1) and the...
6.
Ersoz O, Melis Soylu H, Er O, Ocakoglu K, Yurt Lambrecht F, Yilmaz O
Cancer Biother Radiopharm
. 2015 Nov;
30(9):395-9.
PMID: 26560195
Imidazolium salts have antitumor potential and toxicological effects on various microorganisms. The authors' aim is to synthesize a new imidazolium salt and to assess its pharmacokinetic and antitumor potentials by...
7.
Ince M, Er O, Ocakoglu K, Yurt Lambrecht F, Colak S, Melis Soylu H, et al.
Chem Biol Drug Des
. 2015 Sep;
87(2):224-32.
PMID: 26348246
Novel octylthio-containing asymmetrically substituted Zn(II) phthalocyanine (Zn(II)Pc1) and a symmetric derivative (Zn(II)Pc2) have been prepared to investigate the biological potential and ability to photosensitize singlet oxygen for photodynamic therapy applications....
8.
Ocakoglu K, Er O, Kiyak G, Yurt Lambrecht F, Gunduz C, Kayabasi C
Int J Pharm
. 2015 Jul;
493(1-2):96-101.
PMID: 26226337
In recent years, the photodynamic therapy studies have gained considerable attention as an alternative method to surgery, chemotherapy and radiotherapy which is commonly used to fight cancer. In this study,...
9.
Ocakoglu K, Er O, Yurt Lambrecht F, Yilmaz Susluer S, Kayabasi C, Gunduz C, et al.
J Drug Target
. 2014 Sep;
23(1):89-95.
PMID: 25230852
The biological potential of a synthetic copper chlorophyll derivative was investigated via in vivo and in vitro experiments. The Cu-chlorophyll derivative photosensitizer (Cu-PH-A) was labeled with (131)I with high efficiency...
10.
Altiparmak B, Yurt Lambrecht F, Citak A
Appl Radiat Isot
. 2014 Mar;
89:130-3.
PMID: 24631744
In malignant tissues, MMP-9 (gelatinase B, 92 kDa type IV collagenase) and MMP-2 (gelatinase A, 72 kDa type IV collagenase) are the most prevalent matrix metalloproteinases related to the tumor...